Nermin S Ahmed

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Polycyclic Aromatic Hydrocarbons

Molecular Dynamics Simulations

Breast Cancer Cells

Top Venues

Drug development research

Journal of medicinal chemistry

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Nermin S Ahmed, Heba E El-Nakib, Marian M Ramsis, Nouran O Albably, Jannette Wober, Jan J Weigand, Kai Schwedtmann, Oliver Zierau, Ashraf H Abadi
Structure-Activity Relationships of Triphenylethylene Derivatives and Their Evaluation as Anticancer and Antiviral Agents. ACS omega 8 (29) (2023)
Tammy Mostafa, Miriam Albeir, Jannette Wober, Ashraf Abadi, Ismail Salama, Nermin S Ahmed
Design, synthesis, and in-silico study of novel triarylethylene analogs with dual anti-estrogenic and serotonergic activity. Drug development research (2023)
Mirja Harms, Rikke Fabech Hansson, Andrea Gilg, Yasser Almeida-Hernández, Jessica Löffler, Armando Alexei Rodríguez, Monica M W Habib, Dan Albers, Nermin S Ahmed, Ashraf H Abadi, Gordon Winter, Volker Rasche, Ambros J Beer, Gilbert Weidinger, Nico Preising, Ludger Ständker, Sebastian Wiese, Elsa Sanchez-Garcia, Alexander N Zelikin, Jan Münch
Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability. Journal of medicinal chemistry (2023)
Heba E Elnakib, Marian M Ramsis, Nouran O Albably, Merna A Vector, Jan J Weigand, Kai Schwedtmann, Jannette Wober, Oliver Zierau, Günter Vollmer, Ashraf H Abadi, Nermin S Ahmed
Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs. International journal of molecular sciences 22 (22) (2021)
Nermin S Ahmed, Jannette Wober
Synthesis of novel flexible tamoxifen analogues to overcome CYP2D6 polymorphism and their biological evaluation on MCF-7 cell line. Drug development research 81 (4) (2020)
Nermin S Ahmed
Tadalafil: 15 years' journey in male erectile dysfunction and beyond. Drug development research (2018)